Global Blood Therapeutics Aktie (A14YE6 | GBT

Was macht Global Blood Therapeutics?

Unternehmensprofil

GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and is headquartered in San Francisco, California.

Chart der Global Blood Therapeutics Aktie

Charttool öffnen

Aktuelle Nachrichten zu Global Blood Therapeutics

Das berichten andere über Global Blood Therapeutics

Have $500? 2 High-Yield Dividend Stocks to Buy Right Now

Dividend stocks can be a great way to boost your portfolios growth potential or provide a form of passive income over the years. While not all dividend stocks are the same,...

Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?

Shares of Pfizer (NYSE: PFE) recently marched higher in response to a dividend payout raise and a forward-looking presentation. Management confirmed the annual revenue and...

2 High-Yield Dividend Stocks I Cant Stop Buying

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible Trump-era tariffs could complicate the Feds plans,...